Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1992
12/16/1992CN1067052A Substituted diaminophthalimides and analogues
12/15/1992US5171840 Receptor protein for human B cell stimulatory factor-2
12/15/1992US5171835 LHRH antagonists
12/15/1992US5171741 Treating undesired biological target to destroy infected cells or viruses
12/15/1992US5171665 Monoclonal antibody to novel antigen associated with human tumors
12/15/1992US5171582 Placing sealed plastic container of prilled iodine in distilled water to produce pure aqueous solution
12/15/1992US5171580 Orally-pharmaceutical preparations with colon selective delivery
12/15/1992US5171567 Method for the treatment of atll and the inhalant for the same
12/15/1992CA2071181A1 Benzodiazepine analogs
12/15/1992CA1311501C Calciferol derivatives
12/15/1992CA1311472C 3'-demethoxyepipodophyllotoxin glucoside derivatives
12/15/1992CA1311420C Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
12/14/1992CA2071094A1 Inhibiting agent against the proliferation of malignant tumor cells of animals including human beings and its manufacture
12/12/1992CA2070960A1 Cycloalk-3-ene-1,5-diyne derivatives; process for preparing the same and pharmaceutical compositions containing them
12/10/1992WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992WO1992021670A1 New biotenside ester and phosphatide with vitamin d and vitamin e compounds; their preparation and transformation into spontaneously dispersible concentrates and their use for treating tumors
12/10/1992WO1992021669A1 2-phenylbenzo[b]furans and thiophenes, methods of preparing them and pharmaceutical preparations containing them
12/10/1992WO1992021643A1 Azulenic retinoid compounds, compositions and methods
12/10/1992WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992WO1992021360A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/10/1992WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
12/10/1992WO1992021353A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992WO1992021344A2 Modulation of cellular response to external stimuli
12/10/1992CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992CA2110062A1 2-phenylbenzo[b]furans, processes for their manufacture and pharmaceutical preparations containing them
12/10/1992CA2110040A1 Compositions and delivery systems for transdermal administration of neutral oligomers
12/10/1992CA2102890A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
12/09/1992EP0517484A2 Fermentation analogs of virginiamycin M1
12/09/1992EP0517225A1 Aminopyrrolidine platinum compounds, a process for preparing them and pharmaceutical compositions containing them
12/09/1992EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids
12/09/1992EP0516669A1 Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations
12/09/1992CN1019391B Process for diastereoisomeric tetradrydropyrideo (2,3-d) pyrimidine derivatives
12/09/1992CN1019355B Process for minactivin and its use
12/08/1992US5169860 Antitumor compositions and methods of treatment
12/08/1992US5169836 Inhibitors of platelet binding
12/06/1992WO1992021330A1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition
12/06/1992CA2088910A1 Particulate vector with selective tropism, process for the preparation thereof and pharmaceutical composition
12/06/1992CA2070526A1 Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and pharmaceutical compositions containing them
12/06/1992CA2070508A1 Aminopyrrolidine platinum compounds and process for their production
12/05/1992CA2043864A1 Direct compression cyclophosphamide tablet
12/04/1992WO1992021383A1 Radiolabelled somatostatin derivatives, their preparation and use
12/04/1992WO1992021373A1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS
12/04/1992CA2102633A1 Radiolabelled somatostatin derivatives, their preparation and use
12/04/1992CA2070242A1 Fermentation analogs of virginiamycin m1
12/02/1992EP0516588A1 Substituted diaminophtalimides and analogues
12/02/1992EP0516530A1 New 6-substituted steroids with a thioethyl group in the 10 position, a process for their preparation and intermediates therefor, their use as medicines and pharmaceutical compositions thereof
12/02/1992EP0516410A2 Novel synthesis of 19-nor vitamin D compounds
12/02/1992EP0516257A1 Phenylbenzo[b]furans and -thiophenes, procedures for their preparation, and pharmaceutical compositions containing the same
12/02/1992EP0516194A2 Pharmaceutical compositions containing cationic surfactants
12/02/1992EP0516157A1 Preparation of 6-0-alkylelsamicin A derivatives
12/02/1992EP0516156A1 Chemical modification of 2"-amino group in elsamicin A
12/02/1992EP0516155A1 Chemical modification of elsamicin A at the 3' and/or 4'OH groups
12/02/1992EP0516154A1 Preparation of 6-0-acylelsamicin a derivatives
12/02/1992EP0515540A1 Derivative of beta-phenylisoserine, preparation and utilisation thereof.
12/02/1992EP0515509A1 Novel antiviral and antitumor terpene hydroquinones and methods of use
12/02/1992EP0515386A1 Glycoalkaloids
12/02/1992EP0394283B1 Use of a tripeptide for the preparation of pharmaceutical compositions and a pharmaceutical composition and method
12/02/1992EP0302874B1 Indoloquinone compounds
12/02/1992CN1066660A Peptide compound and process for preparation thereof
12/01/1992US5168053 Ribonuclease and genetically-engineered external guide sequence of nucleotides as treatment for AIDS
12/01/1992US5167963 8,10-dideazatetrahydrofolic acid derivatives
12/01/1992CA2069857A1 Substituted diaminophthalimides and analogues
12/01/1992CA2069717A1 Chemical modification of 2"-amino group in elsamicin a
12/01/1992CA2069716A1 Preparation of 6-0-alkylelsamicin a derivatives
12/01/1992CA2069715A1 Chemical modification of elsamicin a at the 3' and/or 4'oh groups
12/01/1992CA2069714A1 Preparation of 6-0-acylelsamicin a derivatives
12/01/1992CA2068744A1 Gallium compounds
12/01/1992CA1310974C Alkane and alkene derivatives and their preparation and use
12/01/1992CA1310965C Indolizine derivatives, process for preparing them and the compositions containing them
12/01/1992CA1310957C 10.beta.-ALKYNYLESTRENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
12/01/1992CA1310924C Infective drug delivery system
12/01/1992CA1310902C Autocrine motility factors in cancer diagnosis and management
11/1992
11/30/1992WO1992021660A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors
11/30/1992WO1992021641A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992WO1992021359A1 Antineoplastic chemotherapeutic of plant origin, having high selectivity and greatly reduced toxicity, and process for the preparation thereof
11/30/1992CA2109515A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992CA2108889A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors
11/30/1992CA2069469A1 Bicyclic rapamycins
11/30/1992CA2069468A1 Rapamycin dimers
11/28/1992CA2069570A1 6-substituted steroid products containing a thioethyl group in position 10; process for preparing the same and intermediate compounds thereof; their use as therapeutic agents and pharmaceutical products containing them
11/26/1992WO1992021033A1 Determination of motifs of peptides on mhc molecules
11/26/1992WO1992020816A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/26/1992WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY
11/26/1992WO1992020707A1 Bombesin analogs
11/26/1992WO1992020650A2 Phosphite-borane compounds, and method of making and using the same
11/26/1992WO1992020646A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them
11/26/1992WO1992020643A1 Novel bi-aromatic compounds derived from a salicilic pattern, method of preparation and use in human and veterinary medecine and in cosmetics
11/26/1992WO1992020642A1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
11/26/1992WO1992020374A1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78
11/26/1992WO1992020363A1 Treatment of liver cancer
11/26/1992WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
11/26/1992WO1992020348A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
11/26/1992WO1992020347A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
11/26/1992WO1992020344A1 Antiviral combinations containing nucleoside analogs
11/26/1992WO1992018536A3 Method for detecting an localizing tissues having neurokinine 1 receptors
11/26/1992CA2471093A1 Determination of motifs of peptides on mhc molecules
11/26/1992CA2109829A1 Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
11/26/1992CA2109206A1 Treatment of liver cancer
11/26/1992CA2103050A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/26/1992CA2102422A1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78
1 ... 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 ... 2211